Indeed, the reduction of Smad3-mediated renal fibrosis was observed in mouse models of chronic kidney diseases overexpressing miR-29 and miR-200, or showing decreased expression of miR-21 and miR-192 [66,67]. Here, SMAD3 is linked to chronic kidney disease.